ACB $0.837 (4.6%)

ACNNF $0.120 (0%)

AERO $1.420 (-2.07%)

AGEEF $0.095 (0.21%)

ALEAF $0.257 (-1.41%)

AMMJ $0.098 (-6.8%)

APHA $3.150 (3.62%)

ARNA $46.810 (-1.12%)

ATT:CNX $0.080 (0%)

ATTBF $0.006 (3.24%)

AUSA:CNX $0.185 (0%)

AUSAF $0.129 (-0.16%)

AVXL $2.850 (-3.39%)

BAMM:CNX $0.280 (-3.45%)

BBM:CNX $0.065 (0%)

BBRRF $0.049 (12.64%)

BE:CNX $0.015 (50%)

BIO:CNX $0.060 (0%)

BLEVF $0.015 (0%)

BLO:CNX $0.390 (4%)

BLOZF $0.267 (3.17%)

BUDZ $0.220 (-7.95%)

BXNG $0.357 (37.31%)

CADMF $0.604 (18.02%)

CALI:CNX $0.060 (0%)

CANN $0.430 (-2.27%)

CARA $13.360 (-0.3%)

CBII:CNX $0.075 (7.14%)

CBIIF $0.054 (-12.05%)

CBWTF $0.237 (0.21%)

CGC $14.790 (2%)

CGRW $0.049 (-2%)

CHOO:CNX $0.090 (5.88%)

CHOOF $0.063 (4.17%)

CNAB $0.058 (-4.17%)

CNBX $0.162 (0.28%)

CNGGF $0.520 (0%)

CODI $15.280 (5.6%)

CPMD $0.425 (0%)

CRBP $5.110 (-1.54%)

CRON $5.620 (-2.6%)

CRTPF $1.775 (0.28%)

CRXPF $0.031 (30.3%)

CSI:CNX $0.890 (9.88%)

CTST $0.638 (0%)

CURR $2.200 (0%)

CVSI $0.640 (-5.19%)

DIGP $0.058 (-10.63%)

DXBRF $0.140 (0%)

EAPH $0.001 (-16.67%)

EAT:CNX $0.020 (-20%)

EEVVF $0.062 (0.73%)

EMHTF $0.116 (1.4%)

EPWCF $0.020 (0%)

EVIO $0.021 (4.95%)

FFRMF $0.018 (-9.77%)

FFT:CNX $0.030 (0%)

FNNZF $0.055 (3.21%)

GGTTF $0.072 (5.35%)

GLDFF $0.011 (-6.78%)

GLH:CNX $0.020 (0%)

GNBT $0.430 (1.42%)

GRIN:CNX $0.090 (0%)

GRWG $3.340 (-0.6%)

GSTR:CNX $0.035 (-12.5%)

GTBIF $5.850 (0%)

GTII:CNX $8.200 (0.24%)

GWPH $91.720 (5.94%)

HEXO $0.506 (-26.67%)

HHPHF $0.015 (0%)

HLSPY $0.433 (-5.97%)

HMLSF $4.136 (1.93%)

HMPPF $0.498 (0%)

HRVOF $0.050 (4.76%)

HSTRF $0.055 (37.5%)

HUGE:CNX $4.750 (2.37%)

IAN:CNX $0.270 (3.85%)

IGC $0.440 (-1.79%)

IGXT $0.159 (13.21%)

IIPR $69.990 (-0.2%)

IMLFF $0.150 (0%)

INQD $0.001 (0%)

IONC:CNX $0.010 (0%)

IONKF $0.006 (-20.21%)

ISOL:CNX $0.090 (-5.26%)

ISOLF $0.070 (0%)

ITHUF $0.193 (7.9%)

IVITF $0.039 (29.17%)

JWCAF $0.020 (20%)

KALTF $0.012 (27.78%)

KBEV:CNX $0.075 (-6.25%)

KBEVF $0.053 (-2.3%)

KHRNF $0.382 (-1.06%)

KSHB $0.607 (2.02%)

LHS:CNX $0.465 (1.09%)

LHSIF $0.329 (1.86%)

LOVE:CNX $0.075 (0%)

LXLLF $0.380 (0%)

LXRP $0.292 (-2.8%)

LXX:CNX $0.410 (-2.38%)

MCIG $0.031 (3.04%)

MDCL $1.370 (5.38%)

MEDIF $1.075 (-1.34%)

MGWFF $0.054 (13.16%)

MICWF $0.039 (54%)

MJ:CNX $0.025 (25%)

MJNA $0.015 (0%)

MNTR $0.095 (5.56%)

MRRCF $0.007 (-10.34%)

MWM:CNX $0.050 (11.11%)

MYM:CNX $0.080 (6.67%)

MYMMF $0.047 (14.47%)

NCNNF $0.101 (1.2%)

NDVAF $0.150 (-1.7%)

NGW:CNX $0.060 (-7.69%)

NRXCF $0.018 (0%)

NSPDF $0.023 (-10.85%)

NTEC $0.183 (-1.3%)

NVTQF $0.099 (0%)

NWKRF $0.424 (0%)

NXGWF $0.048 (5.56%)

NXTTF $0.209 (-0.48%)

ORHOF $4.050 (0%)

OWCP $0.010 (5.56%)

PHVAF $0.046 (-6.31%)

PILL:CNX $0.500 (0%)

PKG:CNX $0.090 (0%)

PLPRF $0.440 (2.18%)

PLUS:CNX $0.600 (-1.64%)

PMCB $0.030 (-6.33%)

PNPL $0.210 (0%)

POTN $0.011 (0.47%)

PRCNF $0.019 (6.63%)

PTNYF $0.064 (8.07%)

QCA:CNX $0.065 (8.33%)

RDDTF $0.130 (4.2%)

RLLVF $0.040 (-14.89%)

RMHB $0.020 (1.8%)

RQB:CNX $0.005 (-50%)

RQHTF $0.288 (-0.07%)

RVVQF $0.006 (28.72%)

SLNG:CNX $0.155 (3.33%)

SMG $102.500 (1.14%)

SNN:CNX $0.195 (8.33%)

SNNVF $0.126 (14.55%)

SOL:CNX $0.235 (2.17%)

SOLCF $0.173 (5.49%)

SPLIF $0.013 (-28.33%)

SPRWF $0.198 (1.54%)

SRNA $0.033 (6.45%)

STEM:CNX $0.530 (3.92%)

STMH $0.360 (-5.26%)

SUN:CNX $0.090 (5.88%)

TBPMF $0.210 (20.97%)

TCAN:CNX $0.820 (-2.38%)

TCNAF $0.504 (-1.25%)

TER:CNX $2.360 (-1.67%)

TGEN $0.923 (2.53%)

TGIF:CNX $0.070 (-6.67%)

TGIFF $0.054 (-1.65%)

THC:CNX $0.110 (0%)

THCBF $0.080 (13.39%)

TLRY $6.370 (6.88%)

TOKI:CNX $0.015 (0%)

TRLFF $0.019 (-2.09%)

TRPX $0.306 (9.26%)

TRSSF $1.731 (-1.73%)

TRTC $0.075 (-3.35%)

TURV $0.040 (6.67%)

VBIO $0.060 (-16.81%)

VIDA:CNX $0.060 (-7.69%)

VIN:CNX $0.015 (0%)

VPRB $0.025 (0.41%)

VRNDF $0.325 (-1.71%)

VRT:CNX $0.190 (0%)

VRTHF $0.141 (28.23%)

VVCIF $0.155 (6.08%)

WAYL:CNX $0.740 (0%)

WDDMF $0.279 (-0.39%)

WLDFF $0.064 (5%)

XXII $0.695 (2.06%)

ZDPY $0.150 (8.54%)

ZYNE $3.470 (-3.88%)

Loading...
On Friday, Canabo Medical (CMM.V: TSX Venture) (CAMDF: OTCQB) released the results of an observational study that connected doctor-supervised medical cannabis treatments to a decrease in benzodiazepine reliance among Canadian patients. The team responsible for the report shared its findings with several Canadian medical journals and details are expected to be released in the Dalhousie […]
To access this content, you must purchase Technical420 Premium Membership, Yearly or Technical420 Premium Membership, Monthly.